August 26, 2024JCR Journal of Clinical Rheumatology

Transition to Adult Care in Autoinflammatory Diseases

View Full Paper

Ask AI

Bookmark

Evidence evaluating structured transition programs remains critically limited, particularly for individuals with monogenic autoinflammatory diseases.
Clinical management guidelines recommend transition pathways, yet empirical validation of their efficacy in pediatric care continuity is currently lacking.
Closing this evidence gap is necessary to ensure unbroken continuity of care, which directly supports long-term disease management across life stages.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Review reveals limited evidence for transition program efficacy in monogenic autoinflammatory diseases, highlighting the need for structured continuity of care.

Cite This Study

Elhani et al. (2024) studied this question.

synapsesocial.com/papers/68e5adceb6db64358754788c https://doi.org/10.1097/rhu.0000000000002132

View Full Paper

Ask AI

Bookmark

Implication

Review reveals limited evidence for transition program efficacy in monogenic autoinflammatory diseases, highlighting the need for structured continuity of care.

Transition to Adult Care in Autoinflammatory Diseases

Key Points

Discussion

Implication

Cite This Study

Transition to Adult Care in Autoinflammatory Diseases

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider